Product Information
RBN-2397 is a poly-adp-ribose polymerase inhibitor that has been shown to have clinical efficacy in the treatment of cancer. RBN-2397 is a molecule that inhibits the activity of poly-adp-ribose polymerase (PARP), an enzyme involved in the homologous recombination repair of DNA. This inhibition leads to DNA damage and cell death by apoptosis, which are associated with tumor development and progression. RBN-2397 has been shown to be effective as an adjunct therapy for people with metastatic melanoma or other cancers who are resistant to interferon alfa-2b and cytosolic colony stimulating factor.
Chemical properties
Technical inquiry about: 3D-GVD03782 RBN-2397
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
